Drug-coated balloons for small coronary artery disease
07 October 2018
|Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial||Jeger RV, et al.|
|In small native coronary artery disease, DCB was non-inferior to DES regarding MACE up to 12 months, with similar event rates for both treatment groups.||The Lancet, Articles| Volume 392, ISSUE 10150, P849-856, September 08, 2018, https://doi.org/10.1016/S0140-6736(18)31719-7|
|This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.|
Find NEWS and PUBLICATIONS here according to your interests or use the search box.